A Computational Approach to the Study of the Binding Mode of S1PR Agonists Based on the Active-Like Receptor Model.

J Chem Inf Model

State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica , Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050 , P.R. China.

Published: April 2019

Sphingosine-1-phosphate receptor 1 (S1PR), a member of the G protein-coupled receptor (GPCR) family, is an attractive protein target for the treatment of autoimmune diseases, and a diverse array of S1PR agonists have been developed. Rational drug design based on S1PR remains challenging due to the limited information available on the binding mode between S1PR and its agonists. In this work, the active-like state of S1PR was modeled via Gaussian accelerated molecular dynamics (GaMD) based on its inactive form, which was further validated by docking studies with two representative S1PR agonists. Moreover, with the usage of the induced active-like state, the binding mode between S1PR and its agonists was studied through molecular dynamics simulations and MM-GBSA calculations. The results of those studies indicated that four groups of binding site residues were the major contributors to the ligand and receptor interactions. In addition, this model was verified by five chemically similar compounds synthesized in-house and 1145 known S1PR agonists collected from the BindingDB database. The elucidation of the key binding characteristics will further complete the cognition of S1PR, which can guide the rational design of novel S1PR agonists.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jcim.8b00764DOI Listing

Publication Analysis

Top Keywords

s1pr agonists
28
binding mode
12
mode s1pr
12
s1pr
11
active-like state
8
molecular dynamics
8
agonists
7
binding
5
computational approach
4
approach study
4

Similar Publications

Effects of Sphingosine-1-Phosphate on the Facilitation of Peripheral Nerve Regeneration.

Cureus

November 2024

Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JPN.

This study aims to explore the role of sphingosine-1-phosphate (S1P) in peripheral nerve regeneration after injury. S1P is a crucial metabolite involved in cell migration, inflammation, and nerve regeneration. In this research, six-week-old male Sprague-Dawley rats (total n=18) underwent transection of the inferior alveolar nerve (IAN) and were divided into three groups: S1PR agonist (FTY720) (n=6), saline control (n=6), and S1P1R antagonist (n=6).

View Article and Find Full Text PDF

Sphingosine-1-phosphate (S1P) receptor (S1PR) agonists, such as fingolimod (FTY720), alleviate nociception in preclinical pain models by either activation (agonism) or inhibition (functional antagonism) of S1PR type-1 (S1PR1). However, the dose-dependence and temporal relationship between reversal of nociception and modulation of S1PR1 signaling has not been systematically investigated. This study examined the relationship between FTY720-induced antinociception and S1PR1 adaptation using a sciatic nerve chronic constriction injury (CCI) model of neuropathic pain in male and female C57Bl/6J mice.

View Article and Find Full Text PDF

Lysophospholipid receptors in neurodegeneration and neuroprotection.

Explor Neuroprotective Ther

August 2024

Department of Biology, Winthrop University, Rock Hill, SC 29733, USA.

The central nervous system (CNS) is one of the most complex physiological systems, and treatment of CNS disorders represents an area of major medical need. One critical aspect of the CNS is its lack of regeneration, such that damage is often permanent. The damage often leads to neurodegeneration, and so strategies for neuroprotection could lead to major medical advances.

View Article and Find Full Text PDF

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.

Front Immunol

June 2024

Synaptic Immunopathology Lab, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Roma, Rome, Italy.

Article Synopsis
  • SPMS progresses from a relapsing-remitting phase and is marked by increasing disability, but lacks a reliable tool to track this transition; T cells from RRMS patients worsen neuron function, indicating synaptotoxic effects in SPMS.
  • The study collected data from healthy controls and SPMS patients, analyzing the effects of siponimod on T cell interactions in brain slices and using animal models to pinpoint how siponimod helps.
  • Results showed that T cells from SPMS patients increased excitatory signals in neurons compared to healthy controls, while siponimod reversed this toxicity, suggesting it could be a vital treatment strategy for managing SPMS.
View Article and Find Full Text PDF
Article Synopsis
  • * S1PR modulators can cross the blood-brain barrier, affecting immune cells and helping to treat Multiple Sclerosis, with three currently approved medications and more under development.
  • * Ongoing research is examining S1P modulators for use in neurodegenerative diseases, highlighting the need for new therapies and detailing the metabolism and effects of these molecules on the body's systems.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!